Cheng-you Jia
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Future therapeutic implications of new molecular mechanism of colorectal cancer.
Journal: World journal of gastroenterology
Published: October 19, 2022
Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma.
Journal: Frontiers in oncology
Published: April 18, 2022
Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma.
Journal: Journal of advanced research
Published: February 27, 2022
MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.
Journal: Technology in cancer research & treatment
Published: September 14, 2021
Protein disulfide isomerase inhibits endoplasmic reticulum stress response and apoptosis via its oxidoreductase activity in colorectal cancer.
Journal: Cellular signalling
Published: May 11, 2021
Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition.
Journal: Journal of translational medicine
Published: February 15, 2021
microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway.
Journal: Cellular signalling
Published: February 01, 2021
Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.
Journal: Molecular therapy. Nucleic acids
Published: December 13, 2020
MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients.
Journal: International journal of genomics
Published: November 19, 2020
Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
Journal: Disease markers
Published: November 03, 2020
MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65.
Journal: Molecular therapy oncolytics
Published: October 31, 2020
Last Updated: 09/26/2026